No Cumulative Royalties; Aggregation and Allocation of Net Sales for Determining Royalty Rate Breakpoints. (a) In no event shall royalties under more than one of Section 10.3.1 or 10.3.2 (for Exclusive Products) or Section 10.3.3 or 10.3.4 (for Unilateral Products) be payable for the same Licensed Product in a country; however, the [***] of the applicable [***] shall be [***] but, for clarity such royalty rates shall not be cumulative.
Appears in 2 contracts
Samples: License and Collaboration Agreement (Genmab a/S), License and Collaboration Agreement (Genmab a/S)
No Cumulative Royalties; Aggregation and Allocation of Net Sales for Determining Royalty Rate Breakpoints. (a) In no event shall royalties under more than one of Section 10.3.1 or 10.3.2 (for Exclusive Products) or Section 10.3.3 or 10.3.4 (for Unilateral Products) be payable for the same Licensed Product in a country; however, the [***[ * ] of the applicable [***[ * ] shall be [***[ * ] but, for clarity such royalty rates shall not be cumulative.
Appears in 2 contracts
Samples: License and Collaboration Agreement (Seattle Genetics Inc /Wa), License and Collaboration Agreement (Seattle Genetics Inc /Wa)
No Cumulative Royalties; Aggregation and Allocation of Net Sales for Determining Royalty Rate Breakpoints. (a) In no event shall royalties under more than one of Section 10.3.1 9.2.1, 9.2.2, 9.2.3 or 10.3.2 (for Exclusive Products) or Section 10.3.3 or 10.3.4 (for Unilateral Products) 9.2.4 be payable for the same Licensed Product in a country; however, the [***] highest of the applicable [***] royalty rates shall be [***] payable but, for clarity such royalty rates shall not be cumulative.
Appears in 1 contract
